IHE:NYE-iShares U.S. Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 63.6

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.23% 86% B+ 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.23% 86% B+ 38% F
Trailing 12 Months  
Capital Gain -2.81% 71% C- 37% F
Dividend Return 1.00% 88% B+ 21% F
Total Return -1.81% 71% C- 32% F
Trailing 5 Years  
Capital Gain 24.18% 71% C- 46% F
Dividend Return 8.86% 95% A 20% F
Total Return 33.04% 81% B- 38% F
Average Annual (5 Year Horizon)  
Capital Gain 2.59% 67% D+ 48% F
Dividend Return 3.97% 67% D+ 44% F
Total Return 1.38% 100% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.18% 62% D 66% D+
Risk Adjusted Return 27.98% 67% D+ 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike